文献速递关节外科运动医学

Charlson与Elixhauser共病指数对肩关节置换术后患者报告结局的影响

The impact of Charlson and Elixhauser comorbidities on patient outcomes following shoulder arthroplasty.
PubMed 文献 · Bone Joint J · 2021-01-01

研究纳入2016至2018年接受全肩关节置换术、反式肩关节置换术或半肩关节置换术的1817例患者,分析Charlson和Elixhauser共病指数与患者报告结局测量(PROMs)的关联。结果显示,共病数量越多,基线及术后肩关节特异性与一般健康PROMs评分越差,特定共病可用于共享决策管理患者预期。

要点

  • 共病数量越多,基线ASES和SAS评分越低(p<0.001)。
  • Elixhauser共病在术后1年(p=0.002)和2年(p=0.002)仍负向影响ASES和SAS评分。
  • Charlson共病数与基线(p<0.001)和2年(p=0.020)SF-12心理成分评分较低相关。

核心结论

  • 共病数量越多与基线评分较低及肩关节特异性和一般健康PROMs结局较差相关。
  • 特定共病的存在可用于共享决策以管理肩关节置换术患者的预期。

研究设计与样本

  • 回顾性识别2016至2018年接受全肩关节置换术(TSA)、反式肩关节置换术(RSA)或半肩关节置换术(HA)的患者,共1817例肩关节置换术:TSA 1017例(56%)、RSA 726例(40%)、HA 74例(4%)。
  • 平均年龄67岁(SD 10),女性936例(52%)。
  • 从电子病历中提取作为次要诊断的Charlson和Elixhauser共病,并与机构登记处匹配获取PROMs。
  • 使用调整年龄和性别的线性回归模型评估共病数量增加与PROM评分的关联。

主要发现

  • 最常见共病为肥胖(1256例,69%)和高血压(990例,55%)。
  • 共病较多的患者基线ASES和SAS评分较低(p<0.001)。
  • Elixhauser共病在术后1年(p=0.002)和2年(p=0.002)持续负向影响ASES和SAS评分。
  • 共病较多的患者基线PROMIS疼痛干扰较大(p=0.007),但2年时无此关联。
  • Charlson共病数较高与基线(p<0.001)和2年(p=0.020)SF-12心理成分评分较低相关;Elixhauser共病数较高与基线(p<0.001)和2年(p=0.004)SF-12躯体成分评分较低相关。

临床怎么用

  • 在共享决策中可参考特定共病的存在来管理肩关节置换术患者的预期。
  • 共病较多的患者可能基线PROMs评分较低且术后肩关节特异性结局较差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To investigate the impact of the Charlson and Elixhauser comorbidity indices on patient-reported outcomes measures (PROMs) following shoulder arthroplasty. METHODS: Patients undergoing total shoulder arthroplasty (TSA), reverse shoulder arthroplasty (RSA), or hemiarthroplasty (HA) from 2016 to 2018 were identified, along with the Charlson and Elixhauser comorbidities listed as their secondary diagnoses in the electronic medical records. Patients were matched to our institution's registry to obtain their PROMs, including shoulder-specific (American Shoulder and Elbow Society (ASES) and Shoulder Activity Scale (SAS)) and general health scales (12-Item Short Form Survey (SF-12) and Patient-Reported Outcomes Measurement Information System-Pain Interference). Linear regression models adjusting for age and sex were used to evaluate the association between increasing number of comorbidities and PROM scores. A total of 1,817 shoulder arthroplasties were performed: 1,017 (56%) TSA, 726 (40%) RSA, and 74 (4%) HA. The mean age was 67 years (SD 10), and 936 (52%) of the patients were female. RESULTS: The most common comorbidities were obesity (1,256, 69%) and hypertension (990, 55%). Patients with more comorbidities had lower ASES and SAS scores at baseline (p < 0.001). Elixhauser comorbidities continued to negatively impact ASES and SAS scores at one year (p = 0.002) and two-year follow-up (p = 0.002). Patients with more comorbidities reported greater pain interference on PROMIS at baseline (p = 0.007), but not at two years. Higher number of Charlson comorbidities were associated with lower scores on the SF-12 mental component at baseline (p < 0.001) and two years (p = 0.020). Higher number of Elixhauser comorbidities were associated with lower SF-12 physical component scores at baseline (p < 0.001) and two years (p = 0.004). CONCLUSION: Higher number of comorbidities was associated with lower baseline scores and worse outcomes on both shoulder-specific and general health PROMs. The presence of specific comorbidities may be used during shared decision-making to manage expectations for patients undergoing shoulder arthroplasty. Cite this article: Bone Joint J 2021;103-B(5):964-970.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Ling DI, Schneider B, Ode G, et al. The impact of Charlson and Elixhauser comorbidities on patient outcomes following shoulder arthroplasty. Bone Joint J. 2021. PMID: 33934663. doi:10.1302/0301-620X.103B5.BJJ-2020-1503.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。